Description
VISN 6 COAGULATION COST PER TEST FY17
First action · last action
2016-10-01 · 2018-04-12
Transactions
4
First transaction's obligation
$584,853
Base + all options value (sum of deltas)
$475,661
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
3
SDVOSB flag on record
No
Parent IDV
VA24613A0058
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2016-10-01+$584,853= $584,853
- Mod P000012016-10-13+$28,000= $612,853
- Mod P000022017-06-08+$11,628= $624,481
- Mod P000032018-04-12-$148,820= $475,661
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2016-10-01 | +$584,853 | $584,853 | VISN 6 COAGULATION COST PER TEST FY17 |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2016-10-13 | +$28,000 | $612,853 | VISN 6 COAGULATION COST PER TEST FY17; INCLUDED FUNDING INFORMATION FOR BECKLEY |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2017-06-08 | +$11,628 | $624,481 | VISN 6 COAGULATION COST PER TEST FY17; CHARLOTTE AND KERNERSVILLE HCCS ADDED. |
| Mod P00003· CLOSE OUT | 2018-04-12 | −$148,820 | $475,661 | VISN 6 COAGULATION COST PER TEST FY17 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI ND7MY2A4ZUE9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25726N0423 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $28,342 | FY2026 |
| 36C25726A0032 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C24626N0747 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $40,544 | FY2026 |
| 36C25726N0320 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS | $122,245 | FY2026 |
| 36C24926N0502 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · W066 · LEASE OR RENTAL OF EQUIPMENT- INSTRUMENTS AND LABORATORY EQUIPMENT | $93,756 | FY2026 |
| 36C24926N0503 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · W066 · LEASE OR RENTAL OF EQUIPMENT- INSTRUMENTS AND LABORATORY EQUIPMENT | $1,107 | FY2026 |
Other recipients under 6550 from 246-NETWORK CONTRACTING OFFICE 6 (36C246) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24626N0749 | BIOMERIEUX INC | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $165,286 | FY2026 |
| 36C24626N0683 | ROCHE DIAGNOSTICS CORPORATION | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $287,950 | FY2026 |
| 36C24626N0663 | CEPHEID | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $160,463 | FY2026 |
| 36C24626N0534 | CEPHEID | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $472,015 | FY2026 |
| 36C24626N0533 | CEPHEID | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $198,013 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24616J1083_3600_VA24613A0058_3600 · retrieved 2026-09-26.